Monographie - Pentamidine isetionate - Stabilis 4.0

Poslední aktualizace :
29/10/2024

Antibiotikum

Pentamidine isetionate

injekce

Stabilita roztoků

Stabilita směsí

Faktory ovlivňující stabilitu

Kompatibilita

Způsoby aplikace

Odkazy

pdf

Chemický vzorec

Obchodní název

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

DBL Pentamidine isetionate	Malajsie
Manicare	Argentina
Nebupent	USA
Pentacarinat	äpanÏlsko, Belgie, Dánsko, Finsko, Francie, Itálie, Kolumbie, Lucembursko, NÏmecko, Nizozemsko, nový Zéland, Rakousko, Švédsko, Švýcarsko, Velká Británie, ÿecko
Pentam	USA
Pentamidina	äpanÏlsko, Argentina
Pentamidine isethionate	Austrálie, Kanada, Malajsie, USA
Pentamina	Portugalsko

Odkazy

injekce

Odkazy : Pentamidine isetionate

	typ	uveřejnění
36	noviny	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	noviny	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	noviny	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	noviny	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	noviny	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	noviny	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	noviny	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratoř	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	noviny	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	noviny	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	noviny	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	noviny	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratoř	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratoř	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratoř	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratoř	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales